Regulation of IFN-γ production following 2B4 activation in human NK cells

被引:0
|
作者
Johnson, LA
Goldfarb, RH
Mathew, PA
机构
[1] Univ N Texas, Hlth Sci Ctr, Dept Mol Biol & Immunol, Ft Worth, TX 76107 USA
[2] Univ N Texas, Hlth Sci Ctr, Inst Canc Res, Ft Worth, TX 76107 USA
来源
IN VIVO | 2000年 / 14卷 / 05期
关键词
2B4; IFN-gamma; NK cells; transcriptional regulation;
D O I
暂无
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
IFN-gamma is a cytokine that regulates various functions of the immune system. The major producers of IFN-gamma are T cells and NK cells. 2B4 is a novel activating receptor expressed on all human NK cells, a subset of CD8+ T cells, monocytes and basophils. Activation of human NK cells through surface 2B4 enhances NK cell cytolytic function and secretion of IFN-gamma. We have examined the regulation of IFN-gamma production by the human NK cell line YT upon activation through surface 2B4. Our data specifically recognizes 2B4, induces transcriptional activation of IFN-gamma. Partial inhibition of transcription did not prevent the transcriptional upregulation of IFN-gamma. S1 nuclease protection analysis indicated that transcriptional activation as well as mRNA stability may account for the increased production of IFN-gamma by human NK cells following 2B4 stimulations.
引用
收藏
页码:625 / 629
页数:5
相关论文
共 50 条
  • [21] PolyI:C plus IL-2 or IL-12 induce IFN-γ production by human NK cells via autocrine IFN-β
    Duluc, Dorothee
    Tan, Fang
    Scotet, Mari
    Blanchard, Simon
    Fremaux, Isabelle
    Garo, Erwan
    Horvat, Branka
    Eid, Pierre
    Delneste, Yves
    Jeannin, Pascale
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2009, 39 (10) : 2877 - 2884
  • [22] 2B4-mediated activation of human NK cells
    Tangye, SG
    Lanier, LL
    Phillips, JH
    FASEB JOURNAL, 2000, 14 (06): : A1023 - A1023
  • [23] Role of CD16 and 2B4 in activation of cytolytic and cytokine release by bovine NK cells
    Mayer, Sandra V.
    Golde, William
    Scherer, Charles F. C.
    Endsley, Mark
    Estes, Don Mark
    JOURNAL OF IMMUNOLOGY, 2009, 182
  • [24] Activation Receptor-Dependent IFN-γ Production by NK Cells Is Controlled by Transcription, Translation, and the Proteasome
    Piersma, Sytse J.
    Pak-Wittel, Melissa A.
    Lin, Andrea
    Plougastel-Douglas, Beatrice
    Yokoyama, Wayne M.
    JOURNAL OF IMMUNOLOGY, 2019, 203 (07): : 1981 - 1988
  • [25] Regulation of IFN-γ production by B effector 1 cells:: Essential roles for T-bet and the IFN-γ receptor
    Harris, DP
    Goodrich, S
    Gerth, AJ
    Peng, SL
    Lund, FE
    JOURNAL OF IMMUNOLOGY, 2005, 174 (11): : 6781 - 6790
  • [26] Cutting edge:: Innate production of IFN-γ by NK cells is independent of epigenetic modification of the IFN-γ promoter
    Tato, C
    Martins, GA
    High, FA
    DiCioccio, CB
    Reiner, SL
    Hunter, CA
    JOURNAL OF IMMUNOLOGY, 2004, 173 (03): : 1514 - 1517
  • [27] Analysis of the molecular mechanism involved in 2B4-mediated NK cell activation: evidence that human 2B4 is physically and functionally associated with the linker for activation of T cells
    Bottino, C
    Augugliaro, R
    Castriconi, R
    Nanni, M
    Biassoni, R
    Moretta, L
    Moretta, A
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2000, 30 (12) : 3718 - 3722
  • [28] Impaired IFN-γ production and proliferation of NK cells in Multiple Sclerosis
    Luenemann, Anna
    Tackenberg, Bjoern
    DeAngelis, Tracy
    da Silva, Rosa Barreira
    Messmer, Brady
    Vanoaica, Liliana D.
    Miller, Aaron
    Apatoff, Brian
    Lublin, Fred D.
    Luenemann, Jan D.
    Muenz, Christian
    INTERNATIONAL IMMUNOLOGY, 2011, 23 (02) : 139 - 148
  • [29] Activation-Specific Metabolic Requirements for NK Cell IFN-γ Production
    Keppel, Molly P.
    Saucier, Nermina
    Mah, Annelise Y.
    Vogel, Tiphanie P.
    Cooper, Megan A.
    JOURNAL OF IMMUNOLOGY, 2015, 194 (04): : 1954 - 1962
  • [30] IgG-dependent activation of human mast cells following up-regulation of FcγRI by IFN-γ
    Woolhiser, MR
    Okayama, Y
    Gilfillan, AM
    Metcalfe, DD
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2001, 31 (11) : 3298 - 3307